Privia Health Group Inc (PRVA)
Return on equity (ROE)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 14,385 | 12,824 | 14,932 | 18,739 | 23,079 | 38,017 | 32,930 | 15,181 | -10,230 | -39,985 | -49,656 | -211,715 | -188,230 | -172,387 | -146,587 | 31,228 | 31,244 |
| Total stockholders’ equity | US$ in thousands | 635,183,000 | 614,886 | 595,407 | 576,800 | 561,437 | 544,681 | 525,232 | 513,276 | 499,094 | 470,186 | 445,155 | 435,042 | 426,872 | 410,600 | 393,300 | 152,247 | 146,748 |
| ROE | 0.00% | 2.09% | 2.51% | 3.25% | 4.11% | 6.98% | 6.27% | 2.96% | -2.05% | -8.50% | -11.15% | -48.67% | -44.10% | -41.98% | -37.27% | 20.51% | 21.29% |
December 31, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $14,385K ÷ $635,183,000K
= 0.00%
Privia Health Group Inc's return on equity (ROE) has shown fluctuations over the period from December 31, 2020, to December 31, 2024. The ROE started at a healthy level of 21.29% in December 2020, indicating the company's ability to generate profit from shareholders' equity. However, the ROE declined significantly in the subsequent quarters, with negative values recorded from June 2021 to December 2022, suggesting that the company was not effectively utilizing its equity to generate profits.
There was a gradual improvement in the ROE from March 2023 onwards, with positive values recorded in the subsequent quarters. The ROE reached a peak of 6.98% in September 2023 before stabilizing around 2-3% in the following quarters. The ROE eventually declined to 0.00% by December 31, 2024, indicating that the company's profitability relative to shareholders' equity had diminished.
Overall, Privia Health Group Inc's ROE experienced a mix of positive and negative trends over the period under review, reflecting fluctuations in the company's profitability and efficiency in utilizing equity. Analysts would need to closely monitor future ROE trends to assess the company's financial performance and sustainability.
Peer comparison
Dec 31, 2024